Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence of Insulin Resistance and the Potential Modulation of Insulin Resistance by N-acetylcysteine (NAC) in Patients Chronically Infected by the Hepatitis C Virus

NCT00614757 is registered in ClinicalTrials.gov with Midwest Biomedical Research as lead sponsor.

NCT NCT00614757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00614757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence of Insulin Resistance and the Potential Modulation of Insulin Resistance by N-acetylcysteine (NAC) in Patients Chronically Infected by the Hepatitis C Virus
Lead sponsor
Midwest Biomedical Research
Phase
Not applicable
Overall status
Suspended
Start date
May 31, 2005
Completion date
December 31, 2013
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome x